Drug Type Small molecule drug |
Synonyms BVT 116429, BVT116429 |
Target |
Action inhibitors |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H14F4N2OS |
InChIKeyZAZOPXOKXNYGDE-ZDUSSCGKSA-N |
CAS Registry1093418-83-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | Slovakia | 12 Feb 2008 |





